4//SEC Filing
Santos David A 4
Accession 0000905148-25-000299
CIK 0001034842other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:47 PM ET
Size
7.3 KB
Accession
0000905148-25-000299
Insider Transaction Report
Form 4
Santos David A
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2025-01-29+19,717→ 55,625 total - Award
Employee Stock Option (Right to Buy)
2025-01-29+14,788→ 14,788 totalExercise: $22.49Exp: 2035-01-29→ Common Stock (14,788 underlying)
Footnotes (4)
- [F1]The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 10, 2025, with the first annual vest occurring on February 10, 2026.
- [F2]This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F3]Includes 999 shares acquired under the Issuer's stock purchase plan.
- [F4]The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continuous service to the Issuer through each such period.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001820066
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:47 PM ET
- Size
- 7.3 KB